The requirements may include: BMI greater than 27 with a co-morbidity or a BMI greater than 30 without Mandate that patient participate in a weight loss management program Ultimately, plans that cover GLP-1s for weight loss want their members to know that the company supports them
If more than 3 days have passed, skip that dose and resume your regular schedule
Whether you are just starting your weight loss journey or seeking the next option after semaglutide or tirzepatide, our team will guide each step and titrate your dose as necessary
severe gastrointestinal disease or gastroparesis
it is not approved by the FDA or EMA for any use, and its Phase 3 TRIUMPH program is still ongoing
Who Retatrutide Is For and Who Should Avoid It Retatrutide is currently studied in adults with obesity, adults with type 2 diabetes, and adults with weight-related conditions like knee osteoarthritis, sleep apnea, and metabolic dysfunction-associated steatotic liver disease (MASLD)
